We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Pinduoduo
PDD
$118B
| $43M | 0.29% |
338,743
+9,543
| +3% | +$1.24M |
|
|
ARNA
77
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $42.7M | 0.29% |
626,318
+194,269
| +45% | +$12.7M |
|
78
Stryker
SYK
$127B
| $42.6M | 0.29% |
163,903
+131,471
| +405% | +$33.6M |
|
79
Advanced Drainage Systems
WMS
$10.9B
| $42.4M | 0.29% |
363,888
+30,503
| +9% | +$3.39M |
|
80
Intuitive Surgical
ISRG
$121B
| $42.2M | 0.29% |
137,718
+10,536
| +8% | +$2.96M |
|
81
Universal Display
OLED
$3.71B
| $41.5M | 0.28% |
186,448
+38,461
| +26% | +$8.42M |
|
|
TPTX
82
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $40.6M | 0.28% |
520,625
+63,684
| +14% | +$4.71M |
|
83
Comcast
CMCSA
$79.1B
| $40.3M | 0.28% |
706,768
+390,344
| +123% | +$21.8M |
|
84
United Parcel Service
UPS
$97.6B
| $39.9M | 0.27% |
191,681
+44,744
| +30% | +$8.95M |
|
85
AbbVie
ABBV
$458B
| $39.6M | 0.27% |
351,856
-178,225
| -34% | -$20.1M |
|
86
Cisco
CSCO
$450B
| $39M | 0.27% |
716,786
-589,746
| -45% | -$31M |
|
87
Baidu
BIDU
$35.8B
| $38.9M | 0.27% |
190,589
+41,117
| +28% | +$8.23M |
|
88
NextEra Energy
NEE
$187B
| $38.9M | 0.27% |
530,240
+253,434
| +92% | +$19M |
|
89
Varonis Systems
VRNS
$5.25B
| $37.8M | 0.26% |
656,431
+508,309
| +343% | +$26.5M |
|
|
SCHW
90
Charles Schwab
SCHW
$177B
| $37.8M | 0.26% |
518,683
+422,106
| +437% | +$29.9M |
|
|
SAIL
91
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $37.7M | 0.26% |
+738,233
| New | +$35.5M |
|
92
3M
MMM
$89B
| $37.6M | 0.26% |
226,638
+96,434
| +74% | +$16.1M |
|
93
Ascendis Pharma A/S
ASND
$16.7B
| $37.2M | 0.25% |
282,980
+42,309
| +18% | +$5.64M |
|
|
94
Bio-Rad Laboratories Class A
BIO
$8.42B
| $36.9M | 0.25% |
57,258
-73,514
| -56% | -$44.7M |
|
95
Sociedad Química y Minera de Chile
SQM
$19.6B
| $36.4M | 0.25% |
769,795
+62,995
| +9% | +$3.1M |
|
96
Xylem
XYL
$28.5B
| $35.8M | 0.25% |
298,431
-50,684
| -15% | -$5.79M |
|
97
S&P Global
SPGI
$126B
| $35.7M | 0.24% |
87,069
-43,594
| -33% | -$16.8M |
|
98
Silicon Laboratories
SLAB
$7.15B
| $35.5M | 0.24% |
231,369
+8,683
| +4% | +$1.21M |
|
|
SPLK
99
DELISTED
Splunk Inc
SPLK
| $34.5M | 0.24% |
238,889
+689
| +0.3% | +$87.7K |
|
100
Ball Corp
BALL
$17B
| $34.3M | 0.23% |
423,434
-90,674
| -18% | -$7.85M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.